215 related articles for article (PubMed ID: 8378281)
1. [Severe infections caused by methicillin-resistant Staphylococcus aureus. 62 cases].
May T; Janbon F; Beuscart C; Meyran M; Roue R
Presse Med; 1993 May; 22(19):909-13. PubMed ID: 8378281
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
Drago L; De Vecchi E; Nicola L; Gismondo MR
BMC Infect Dis; 2007 Sep; 7():111. PubMed ID: 17888153
[TBL] [Abstract][Full Text] [Related]
3. [Antibiotic susceptibility of Staphylococcus aureus strains isolated in two university hospitals in Rabat, Morocco].
Elhamzaoui S; Benouda A; Allali F; Abouqual R; Elouennass M
Med Mal Infect; 2009 Dec; 39(12):891-5. PubMed ID: 19269758
[TBL] [Abstract][Full Text] [Related]
4. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
Coombs GW; Nimmo GR; Daly DA; Le TT; Pearson JC; Tan HL; Robinson JO; Collignon PJ; McLaws ML; Turnidge JD;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E309-19. PubMed ID: 25631593
[TBL] [Abstract][Full Text] [Related]
5. [Severe methicillin-resistant Staphylococcus aureus infections. Emergence of resistance to fusidic acid or fosfomycin during treatment with continuous infusion of vancomycin].
Georges B; Brown L; Mazerolles M; Decun JF; Cougot P; Archambaud M; Suc C; Andrieu P; Virenque C
Presse Med; 1997 Apr; 26(11):502-6. PubMed ID: 9137379
[TBL] [Abstract][Full Text] [Related]
6. [The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Vitkauskiene A; Sakalauskas R; Dudzevicius V
Medicina (Kaunas); 2003; 39(3):254-9. PubMed ID: 12695638
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of 18 antimicrobial agents against Staphylococcus aureus isolates from the Institut Pasteur of Madagascar.
Randrianirina F; Soares JL; Ratsima E; Carod JF; Combe P; Grosjean P; Richard V; Talarmin A
Ann Clin Microbiol Antimicrob; 2007 May; 6():5. PubMed ID: 17521424
[TBL] [Abstract][Full Text] [Related]
8. Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
Tarasi A; Cassone M; Monaco M; Tarasi D; Pompeo ME; Venditti M
J Chemother; 2003 Jun; 15(3):239-43. PubMed ID: 12868549
[TBL] [Abstract][Full Text] [Related]
9. Treatment of infection and colonization caused by methicillin-resistant Staphylococcus aureus.
Chambers HF
Infect Control Hosp Epidemiol; 1991 Jan; 12(1):29-35. PubMed ID: 1847961
[TBL] [Abstract][Full Text] [Related]
10. [Transmission of methicillin-resistant Staphylococcus aureus strains by foreign patients--measures for treating patients and preventing a nosocomial infection].
Neifer S; Markoff C; Braulke C; Witte W
Zentralbl Chir; 1997; 122(7):595-6. PubMed ID: 9340968
[No Abstract] [Full Text] [Related]
11. Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy.
Gómez J; García-Vázquez E; Baños R; Canteras M; Ruiz J; Baños V; Herrero JA; Valdés M
Eur J Clin Microbiol Infect Dis; 2007 Apr; 26(4):239-45. PubMed ID: 17318479
[TBL] [Abstract][Full Text] [Related]
12. [Antibiotic susceptibility of Staphylococcus aureus strains responsible for community-acquired skin infections].
Bernard P; Jarlier V; Santerre-Henriksen A
Ann Dermatol Venereol; 2008 Jan; 135(1):13-9. PubMed ID: 18342068
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
Nikolaidis P; Metallidis S; Katikaridou E; Chatzidimitriou M; Kollaras P; Tsona A; Koumentaki E; Tourkantonis A
J Chemother; 2002 Dec; 14(6):544-6. PubMed ID: 12583543
[TBL] [Abstract][Full Text] [Related]
14. Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use.
Garrouste-Orgeas M; Timsit JF; Kallel H; Ben Ali A; Dumay MF; Paoli B; Misset B; Carlet J
Infect Control Hosp Epidemiol; 2001 Nov; 22(11):687-92. PubMed ID: 11842988
[TBL] [Abstract][Full Text] [Related]
15. [Staphylococcus aureus sepsis in hospitalized non neutropenic patients: retrospective clinical and microbiological analysis].
Falcone M; Carfagna P; Cassone M; Pistella E; Pavoni G; Nofroni I; Serra P; Venditti M
Ann Ital Med Int; 2002; 17(3):166-72. PubMed ID: 12402664
[TBL] [Abstract][Full Text] [Related]
16. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
[TBL] [Abstract][Full Text] [Related]
17. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
[TBL] [Abstract][Full Text] [Related]
18. [An evaluation study on arbekacin for MRSA-infectious diseases including pneumonia, septicemia and others].
Odagiri S; Sumitomo M; Takahashi K; Matsumoto F; Sakurai I; Imai T; Yoshikawa K; Ito A; Sugiyama M; Suzuki M
Jpn J Antibiot; 1994 Jun; 47(6):751-62. PubMed ID: 8072184
[TBL] [Abstract][Full Text] [Related]
19. [MRSA (methicillin-resistant Staphylococcus aureus) infections in patients with pulmonary diseases].
Erbes R; Wagner A; Schaberg T; Lode H; Mauch H; Witte W
Pneumologie; 1996 Oct; 50(10):706-11. PubMed ID: 9019751
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of telavancin (TD-6424), a rapidly bactericidal lipoglycopeptide with multiple mechanisms of action, in a murine model of pneumonia induced by methicillin-resistant Staphylococcus aureus.
Reyes N; Skinner R; Kaniga K; Krause KM; Shelton J; Obedencio GP; Gough A; Conner M; Hegde SS
Antimicrob Agents Chemother; 2005 Oct; 49(10):4344-6. PubMed ID: 16189117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]